Beta-lactamase inhibitor

This page covers all Beta-lactamase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Serine beta-lactamases and metallo-beta-lactamases, beta-lactamase, Serine beta-lactamase-like protein LACTB, mitochondrial.

Targets

Serine beta-lactamases and metallo-beta-lactamases · beta-lactamase · Serine beta-lactamase-like protein LACTB, mitochondrial

Marketed (6)

• Avibactam (AVI) · Pfizer · Infectious Disease
  Avibactam is a beta-lactamase inhibitor that protects beta-lactam antibiotics from enzymatic degradation by binding to and inactivating bacterial beta-lactamases.
• continuous pivotal βL-AB · Assistance Publique - Hôpitaux de Paris · Infectious Diseases
  βL-AB is a beta-lactamase inhibitor that works by inhibiting the bacterial enzyme beta-lactamase, which breaks down beta-lactam antibiotics.
• Zosyn · Merck Sharp & Dohme B.V. · Metabolic
  Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
• Xacduro (Copackaged) · Entasis Therap · Infectious Disease
  Xacduro works by binding to and inhibiting bacterial beta-lactamases, allowing antibiotics to effectively kill bacteria.
• Augmentin 250 · Dr Reddys Labs Inc · Metabolic
• Unasyn · Pfizer · Metabolic